Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupradiotherapyUrologic OncologyDiseaseBladder CancerSubgroupICD10C67.-MeSHCarcinoma, Transitional CellUrinary Bladder NeoplasmsUrogenital NeoplasmsUrologic NeoplasmsSequenceChemotherapyChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinChemo-substanceCapecitabineCisplatinFluorouracilGemcitabineMitomycinNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesium sulfatePotassium chlorideNo. Substances26Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksEmetogenicity (ASCO)Emetogenicity (MASCC/ESMO)Gastrointestinal ToxicityRash only studiesPublicationAuthorChoudhury ACoppin CMde Haar-Holleman AJames NDiseaseHarnblasenkarzinom, muskelinvasiv, nicht metastasiert, ECOG 0-2Muskelinvasives Harnblasenkarzinom, cT2-cT4b, cN0-N3, cM0 Urothelkarzinom, cT2-4a cN0-2/x cM0/xUrothelkarzinom T2-3, N0, M0 nach transurethraler ResektionOriginFront the British Columbia Cancer Agency Vancouver Cancer Centre, CanadaThe Christie NHS Foundation Trust, Wilmslow Rd, Manchester, United KingdomUniversitair Ziekenhuis Brussel, Brussels, Belgium, BlaZIB study University of Birmingham, School of Cancer Sciences, UKProtocols in Revision 4 protocols foundProtocols under revision.Capecitabine 825 / Mitomycin 12 / Radiation, Bladder Cancer (PID2505)Cisplatin 100 / Radiation, Bladder Cancer (PID1668)Fluorouracil 500 / Mitomycin 12 / Radiation, Bladder Cancer (PID949)Gemcitabine 100 / Radiation, Bladder Cancer (PID2213)
